Author

Seyed-Mahdi Mohamadi-Zarch

Observed names: Seyed Mahdi Mohamadi-Zarch, Seyed Mahdi Mohammadi-Zarch
ORCID: 0000-0002-7699-1790
Observed ORCID: 0000-0002-7699-1790
OpenAlex ID: A5030073062
2019 · Tourandokht Baluchnejadmojarad, Seyed-Mahdi Mohamadi-Zarch, et al. · Metabolic Brain Disease · 81
2020 · Seyed-Mahdi Mohamadi-Zarch, Tourandokht Baluchnejadmojarad, et al. · Microbial Pathogenesis · 47
2025 · Ali Mohammadkhanizadeh, Mohammad Sheibani, et al. · Brain Disorders · 20
2024 · Morteza Nazari-Serenjeh, Tourandokht Baluchnejadmojarad, et al. · Heliyon · 16
2021 · Seyed-Mahdi Mohamadi-Zarch, Tourandokht Baluchnejadmojarad, et al. · PubMed Central · 15
2022 · Samira Ramazi, Javad Fahanik-Babaei, et al. · Journal of Chemical Neuroanatomy · 7
2024 · Raziyeh Mohammadi, Hasan Forouzanfar, et al. · Current Pharmaceutical Biotechnology · 6
2024 · Mohammad Amin Ghaffari Sirizi, Mansour Esmailidehaj, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 4
2025 · Tahere Barabadi, Elahe Sadat Mirjalili, et al. · CNS & Neurological Disorders - Drug Targets · 2
2024 · Fariborz Keshmirshekan, Seyed-Mahdi Mohamadi-Zarch, et al. · Anti-Cancer Agents in Medicinal Chemistry · 2
2025 · Tahere Barabadi, Hossein Rahimi, et al. · Current Cancer Drug Targets · 1
2026 · Mohadeseh Dashtaki, Shahrad Shahini, et al. · Current Pharmaceutical Design
2026 · Reza Hooshyari Ardakani, Mohadeseh Dashtaki, et al. · CNS & Neurological Disorders - Drug Targets
2026 · Elahe Sadat Mirjalili, Seyed Mahdi Mohammadi-Zarch, et al. · Current Pharmaceutical Design
2026 · Mobina Karimzadeh, Marzieh Zarin, et al. · Anti-Cancer Agents in Medicinal Chemistry
2025 · Reyhane Faghih, Mehrshad Talebi-Esmaeilan, et al. · Anti-Cancer Agents in Medicinal Chemistry
Works count: 20
Citation count: 283
H-index: 7
I10-index: 7
Year
Topic
Type